IPOs, NCDs, OFS, Rights Issues, Buyback and Stock Brokers
Hexagon Nutrition IPO Details
Bookbuilding IPO | ₹139 Cr | Listing at BSE, NSE | Fri, Jun 5, 2026 - Tue, Jun 9, 2026
Hexagon Nutrition IPO is a book build issue of ₹138.87 crores. The issue is entirely an offer for sale of 3.09 crore shares of ₹138.87 crore.
Hexagon Nutrition IPO opens for subscription on Jun 5, 2026 and closes on Jun 9, 2026. The allotment for the Hexagon Nutrition IPO is expected to be finalized on Jun 10, 2026. Hexagon Nutrition IPO will list on NSE and BSE with a tentative listing date fixed as Jun 12, 2026.
Hexagon Nutrition IPO is set issue price band at ₹42 to ₹45 per share. The lot size for an application is 333 shares. The minimum amount of investment required by an individual investor (retail) is ₹14,985 (333 shares) (based on upper price). The lot size investment for sNII is 14 lots (4,662 shares), amounting to ₹2,09,790, and for bNII, it is 67 lots (22,311 shares), amounting to ₹10,03,995.
Cumulative Capital Pvt.Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue.
Refer to Hexagon Nutrition IPO RHP for detailed Information.
IPO Open
Fri, Jun 5, 2026
IPO Close
Tue, Jun 9, 2026
Price Band
₹42 to ₹45
Market Cap (Pre-IPO)
₹553.13 Cr
IPO Details
-
IPO Date5 to 9 Jun, 2026
-
Listing DateFri, Jun 12, 2026T
-
Face Value₹1 per share
-
Price Band₹42 to ₹45
-
Lot Size333 Shares
-
Sale TypeFresh capital cum OFS
-
Issue TypeBookbuilding IPO
-
Listing AtBSE, NSE
-
Total Issue Size3,08,59,704 shares (agg. up to ₹139 Cr)
-
Offer for Sale3,08,59,704 shares of ₹1 (agg. up to ₹139 Cr)
-
Share Holding Pre Issue12,29,18,109 shares
-
Share Holding Post Issue12,29,18,109 shares
Issue Reservation
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50.00% of the Net Offer |
| Retail Shares Offered | Not less than 35.00% of the Net Offer |
| NII Shares Offered | Not less than 15.00% of the Net Offer |
IPO Lot Size
Investors can bid for a minimum of 333 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 333 | ₹14,985 |
| Retail (Max) | 13 | 4,329 | ₹1,94,805 |
| S-HNI (Min) | 14 | 4,662 | ₹2,09,790 |
| S-HNI (Max) | 66 | 21,978 | ₹9,89,010 |
| B-HNI (Min) | 67 | 22,311 | ₹10,03,995 |
About Hexagon Nutrition Ltd.
Incorporated in 1993, Hexagon Nutrition Ltd. is a research-driven nutrition company. It is engaged in developing and manufacturing products across micronutrient premixes, branded wellness and clinical nutrition, therapeutic formulations, and ready-to-use foods.
The company operates three manufacturing facilities in India, located at Nasik (Maharashtra), Chennai (Tamil Nadu), and Thoothukudi (Tamil Nadu), along with an international unit in Tashkent, Uzbekistan. Two Indian facilities are situated in SEZ zones at Chennai and Thoothukudi, providing strategic advantages such as proximity to ports and duty-free imports.
Its product portfolio is classified into three segments:
- Branded wellness and clinical nutrition products (B2C)
- Premix formulations (B2B2C)
- Ready-to-Use Foods (RUFs) and Micronutrient Powders (MNPs) under ESG initiatives
Hexagon Nutrition has a PAN-India omnichannel distribution network covering retail pharmacies, hospital networks, e-commerce platforms, online pharmacies, and its own branded websites including Pentasure, Obesigo, Pediagold, and Nutrone. For domestic distribution, it works with over 358 distributors across India, including 8 with multi-state presence.
The company has established overseas offices in South Africa, Uzbekistan, and Hong Kong to support international operations. Its products have been exported to more than 75 countries across Asia, Africa, Europe, and South America between fiscals 2023 and 2025.
Hexagon Nutrition maintains two dedicated in-house R&D facilities at Nasik and Chennai, supported by a team of 12 qualified professionals. As of March 31, 2026, the company employed 527 people.
Company Financials (Restated Consolidated)
| Period Ended | 31 Dec 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 327.60 | 261.36 | 250.54 | 288.90 |
| Total Income | 275.57 | 331.29 | 304.62 | 281.65 |
| Profit After Tax | 27.03 | 24.38 | 12.21 | 5.82 |
| EBITDA | 37.55 | 40.07 | 24.88 | 17.17 |
| NET Worth | 223.05 | 195.60 | 176.29 | 163.84 |
| Reserves and Surplus | 210.92 | 183.89 | 164.51 | 152.30 |
| Total Borrowing | 39.79 | 26.60 | 36.89 | 51.87 |
| Amount in ₹ Crore | ||||
Recently Listed IPOs in Pharmaceuticals & Biotechnology
| Company | Issue Type | Issue Size | Listing Day Close | Listing Gain/Loss % |
|---|---|---|---|---|
| Goldline Pharmaceutical Ltd. | SME | ₹11.61 Cr | ₹56.77 | +32.02% |
| Accretion Nutraveda Ltd. | SME | ₹24.77 Cr | ₹191.20 | +48.22% |
| Sai Parenteral’s Ltd. | Mainboard | ₹408.79 Cr | ₹405.70 | +3.49% |
Key Performance Indicator (KPI)
| KPI | Dec 31, 2025 | Mar 31, 2025 |
|---|---|---|
| ROE | 13.02% | 10.47% |
| ROCE | 14.82% | 17.06% |
| Debt/Equity | 0.18 | 0.14 |
| RoNW | 12.12% | 12.46% |
| PAT Margin | 9.81% | 7.36% |
| EBITDA Margin | 14.03% | 12.33% |
| Price to Book Value | 2.48 | 2.83 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 1.98 | 2.93 |
| P/E (x) | 22.69 | 15.35 |
| Promoter Holding | 89.41% | 64.29% |
| Market Cap | ₹553.13 Cr. |
- The value will be calculated using Equity Dilution = Share Holding Pre Issue – Share Holding Post Issue
- The Pre IPO EPS is calculated based on Pre issue shareholding as on date of RHP and the latest FY earnings as of March 31, 2025 available in RHP.
- The Post Issue EPS is calculated based on the Post issue shareholding and annualized FY earnings of December 31, 2025 available in RHP.
IPO Registrar
Kfin Technologies Ltd.
- 04067162222, 04079611000
- hexagon.ipo@kfintech.com
- Visit Website
IPO Lead Manager(s)
- Cumulative Capital Pvt.Ltd. (Past IPO Performance)
- Catalyst Capital Partners Pvt.Ltd. (Past IPO Performance)
Lead Manager Reports
- Lead Manager Performance Summary
- Lead Manager Performance Tracker
Contact Details
- +91 22 6213 6710
- cs.hnpl@hexagonnutrition.com
- Visit Website
IPO FAQs
Hexagon Nutrition IPO is a main-board IPO of 3,08,59,704 equity shares of the face value of ₹1 aggregating up to ₹139 Crores. The issue is priced at ₹42 to ₹45. The minimum order quantity is 333.
The IPO opens on Fri, Jun 5, 2026, and closes on Tue, Jun 9, 2026.
Kfin Technologies Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Angel One customers can apply online in Hexagon Nutrition IPO using UPI as a payment gateway. Angel One customers can apply in Hexagon Nutrition IPO by login into Angel One Console (back office) and submitting an IPO application form.
Steps to apply in Hexagon Nutrition IPO through Angel One
Visit the Angel One website and login to Console.
Go to Portfolio and click the IPOs link.
Go to the ‘Hexagon Nutrition IPO’ row and click the ‘Bid’ button.
Enter your UPI ID, Quantity, and Price.
Submit IPO application form.
Visit the UPI App (net banking or BHIM) to approve the mandate.
Visit Angel One IPO Application Process Review for more detail.
The Hexagon Nutrition IPO opens on Fri, Jun 5, 2026 and closes on Tue, Jun 9, 2026.
Hexagon Nutrition IPO lot size is 333, and the minimum amount required for application is ₹14,985.
You can apply in Hexagon Nutrition IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don’t offer banking services. Read more detail about applying IPO online through Angel One, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Hexagon Nutrition IPO will be done on Wednesday, June 10, 2026, and the allotted shares will be credited to your demat account by Thu, Jun 11, 2026. Check the Hexagon Nutrition IPO allotment status.
The Hexagon Nutrition IPO listing date is not yet announced. The tentative date of listing is Fri, Jun 12, 2026.
Stock Broker Reviews India
